Rho-kinase Inhibitor Y-27632 Reverses Airway Hyperresponsiveness in Asthma
Author Information
Author(s): Schaafsma Dedmer, Bos I Sophie T, Zuidhof Annet B, Zaagsma Johan, Meurs Herman
Primary Institution: University of Groningen
Hypothesis
Does the Rho-kinase inhibitor Y-27632 reverse allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction?
Conclusion
Inhalation of the Rho-kinase inhibitor Y-27632 provides significant bronchoprotection against airway hyperresponsiveness to histamine and PGF2α in allergic asthma.
Supporting Evidence
- Y-27632 significantly decreased basal responsiveness to histamine and PGF2α.
- Y-27632 inhalation reversed airway hyperresponsiveness after both the early and late asthmatic reactions.
- Y-27632 was more effective in reducing airway responsiveness to PGF2α compared to histamine.
Takeaway
This study shows that a special medicine called Y-27632 can help make it easier for people with asthma to breathe after they are exposed to allergens.
Methodology
Guinea pigs were sensitized to ovalbumin and their airway responsiveness was measured before and after inhalation of Y-27632 and allergens.
Limitations
The study was conducted on guinea pigs, which may not fully represent human asthma responses.
Participant Demographics
Outbred specified pathogen-free male Dunkin Hartley guinea pigs, weighing 500–700 g.
Statistical Information
P-Value
0.08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website